The Oncology Institute TOI Stock
The Oncology Institute Price Chart
The Oncology Institute TOI Financial and Trading Overview
| The Oncology Institute stock price | 4.46 USD |
| Previous Close | 3.65 USD |
| Open | 3.69 USD |
| Bid | 3.47 USD x 800 |
| Ask | 3.52 USD x 1500 |
| Day's Range | 3.4 - 3.78 USD |
| 52 Week Range | 0.13 - 3.78 USD |
| Volume | 2.68M USD |
| Avg. Volume | 2.07M USD |
| Market Cap | 321.7M USD |
| Beta (5Y Monthly) | 0.156 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.65 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
TOI Valuation Measures
| Enterprise Value | 245.59M USD |
| Trailing P/E | N/A |
| Forward P/E | -21.875 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.7979569 |
| Price/Book (mrq) | 61.403507 |
| Enterprise Value/Revenue | 0.609 |
| Enterprise Value/EBITDA | -5.401 |
Trading Information
The Oncology Institute Stock Price History
| Beta (5Y Monthly) | 0.156 |
| 52-Week Change | 562.87% |
| S&P500 52-Week Change | 13.16% |
| 52 Week High | 3.78 USD |
| 52 Week Low | 0.13 USD |
| 50-Day Moving Average | 2.75 USD |
| 200-Day Moving Average | 1.28 USD |
TOI Share Statistics
| Avg. Volume (3 month) | 2.07M USD |
| Avg. Daily Volume (10-Days) | 2.65M USD |
| Shares Outstanding | 91.91M |
| Float | 66.95M |
| Short Ratio | 1.11 |
| % Held by Insiders | 9.22% |
| % Held by Institutions | 34.63% |
| Shares Short | 2.41M |
| Short % of Float | 3.20% |
| Short % of Shares Outstanding | 2.61% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | -15.96% |
| Operating Margin (ttm) | -9.49% |
| Gross Margin | 14.70% |
| EBITDA Margin | -11.27% |
Management Effectiveness
| Return on Assets (ttm) | -17.65% |
| Return on Equity (ttm) | -277.61% |
Income Statement
| Revenue (ttm) | 403.15M USD |
| Revenue Per Share (ttm) | 5.32 USD |
| Quarterly Revenue Growth (yoy) | 10.29% |
| Gross Profit (ttm) | 59.28M USD |
| EBITDA | -45475000 USD |
| Net Income Avi to Common (ttm) | -52808000 USD |
| Diluted EPS (ttm) | -0.7 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 39.74M USD |
| Total Cash Per Share (mrq) | 0.45 USD |
| Total Debt (mrq) | 102.4M USD |
| Total Debt/Equity (mrq) | 2020.06 USD |
| Current Ratio (mrq) | 1.794 |
| Book Value Per Share (mrq) | 0.057 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15643000 USD |
| Levered Free Cash Flow (ttm) | 5.58M USD |
Profile of The Oncology Institute
| Country | United States |
| State | CA |
| City | Cerritos |
| Address | 18000 Studebaker Road |
| ZIP | 90703 |
| Phone | 562 735 3226 |
| Website | https://theoncologyinstitute.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 825 |
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Q&A For The Oncology Institute Stock
What is a current TOI stock price?
The Oncology Institute TOI stock price today per share is 4.46 USD.
How to purchase The Oncology Institute stock?
You can buy TOI shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for The Oncology Institute?
The stock symbol or ticker of The Oncology Institute is TOI.
Which industry does the The Oncology Institute company belong to?
The The Oncology Institute industry is Medical Care Facilities.
How many shares does The Oncology Institute have in circulation?
The max supply of The Oncology Institute shares is 96.66M.
What is The Oncology Institute Price to Earnings Ratio (PE Ratio)?
The Oncology Institute PE Ratio is now.
What was The Oncology Institute earnings per share over the trailing 12 months (TTM)?
The Oncology Institute EPS is -0.65 USD over the trailing 12 months.
Which sector does the The Oncology Institute company belong to?
The The Oncology Institute sector is Healthcare.
The Oncology Institute TOI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
- {{ link.label }} {{link}}